• Fri news: Pfizer’s $1B Chinese commitment. RFK Jr. and pharma. Eisai dials back Leqembi forecast. US diabetes burden increase. JNJ gets Varipulse approval. See more on our front page

Castle boasts melanoma test’s capacity to reduce unnecessary testing

cafead

Administrator
Staff member
  • cafead   Nov 07, 2024 at 11:42: AM
via A study showed that using the DecisionDx-Melanoma test resulted in a 25% reduction in unnecessary sentinel lymph node biopsy in cancer patients.

article source